Loading...
 
Mediterr J Rheumatol 2016;27(3):91-3
Assessment of cardiovascular involvement in Connective Tissue Disease: Let’s open Pandora’s box
Authors Information
Onassis Cardiac Surgery Center, Athens, Greece
References
  1. Pohl D, Benseler S . Systemic inflammatory and autoimmune disorders. Handb Clin Neurol 2013;112:1243-52.
  2. Gasparyan AY. Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets. Curr Pharm Des 2012;18:1447-9.
  3. Dimitroulas T, Giannakoulas G, Karvounis H, Garyfallos A, Settas L, Kitas G D. Micro- and macrovascular treatment targets in scleroderma heart disease. Curr Pharm Des 2014;20:536-44.
  4. Al-Dhaher F F, Pope J E, Ouimet J M. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 2010;39:269-77.
  5. Aviña-Zubieta J A, Choi H K, Sadatsafavi M, Etminan M, Esdaile J M, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7.
  6. Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006;2:99-106.
  7. Kitas G D, Gabriel S E. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 2011;70:8-14.
  8. Hollan I, Meroni P L, Ahearn J M, Cohen Tervaert J W, Curran S, Goodyear C S, et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 2013;12:1004-15.
  9. Björnådal L, Yin L, Granath F, Klareskog L, Ekbom A. Cardiovascular disease: a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population-based study 1964-95. J Rheumatol 2004;31:713-9.
  10. Symmons D P, Gabriel S E. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011; 7:399-408.
  11. Kim M N, Kim S A, Kim Y H, Hong S J, Park S M, et al. Head to Head Comparison of Stress Echocardiography with Exercise Electrocardiography for the Detection of Coronary Artery Stenosis in Women. J Cardiovasc Ultrasound 2016;24:135-43.
  12. Meyers H P, Jaffa E, Smith S W, Drake W, Limkakeng A T Jr. Evaluation of T-Wave Morphology in Patients With Left Bundle Branch Block and Suspected Acute Coronary Syndrome. J Emerg Med 2016;51:229-37.
  13. Jhamnani S, Fuisz A, Lindsay J. The spectrum of electrocardiographic manifestations of acute myocarditis: an expanded understanding. J Electrocardiol 2014;47:941-7.
  14. Gibbons R J, Balady G J, Beasley J W, et al. ACC/AHA Guidelines for Exercise Testing. J Am Coll Cardiol 1997;30:260-311.
  15. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al.; European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008;9:415-37.
  16. Hachamovitch R, Berman D S, Kiat H, Cohen I, Cabico J A, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 1996;93:905-14.
  17. Iskander S, Iskandrian A E. Risk assessment using single photon emission computed tomography technetium-99m-sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.
  18. Greenwood J P, Maredia N, Younger J F, Brown J M, Nixon J, Everett C C, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012;379:453-60.
  19. Mavrogeni S I, Kitas G D, Dimitroulas T, Sfikakis P P, Seo P, Gabriel S, et al. Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use. Int J Cardiol 2016;217:135-48.